Well, of course, I am getting yet another beating. Such is

New Post Public Reply Private Reply Replies (0) Message Board
patientgal
Well, of course, I am getting yet another beating. Such is life.

So, here are a few questions:

------Who owns all of the intellectual property (HemaXellerate & the dcellvax)? Think now...

------What company was issued 500,000,000 shares back in May (maybe July...the Nevada SoS site will tell you) I think it was, with a subsequent issuing of some of said stock to Caven Industries? Think now.

------What could Koos possibly gain by shorting BMSN & ENTB stock, decimating the companies? Think now.

------Why hasn't Koos changed the CUSIP for BMSN? Hell, for either? He is still beholden to Asher Enterprises with ENTB and Asher has been linked to many corrupt schemes by way of manipulating stock. If he were at all concerned about the activity with the stock, one would think the beating it has taken since his last so-called PR would be cause for great concern. Yes? No? Not that there has not been plenty of activity that has been cause for great concern before then.

------Why is there STILL a DTC chill issue with ENTB? This doesn't effect everyone. But there is still an issue.

------Who has vast experience in being a broker (and quite possibly is still a licensed broker though not registered with FINRA)?

------Who owns several holding companies that are registered in various states?

------Who seemingly did not know that his stock (BMSN) was being traded on the Berlin Exchange before such was halted by authorities at the behest of European authorities and not BMSN (so he is a broker, with this vast knowledge of business, brokering, stock trading, etc., etc., but didn't know his company was being shorted to hell on the Berlin exchange? uh huh!)

------Who went into several toxic financing deals with companies, relinquishing common and preferred shares of his corporations although said toxic companies have a long history of defrauding shareholders & running scams? (Have you goolgled Steven Hicks yet?) This "venture capitalist" expert? And that is just for BMSN & ENTB.

Do I need to go on? Shall I list the number of documents that come up when you cross reference names and businesses and search SoS sites? The SEC? FINRA? I could be here all day listing material. I am not the only person who has found this material. And I am not the only person that feels that serious nefarious play has been going on and that we were getting mega wool pulled over our eyes.

Now, I hope he proves me wrong. For the sake of we shareholders, I hope he makes some quick changes and proves me to be flat out wrong! Though, the history can all be found with some digging so he can't change that. But, how I would love for David Koos to prove me (us) wrong!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

PS: All patents with respect to Hema & the dcellvax have been executed. There is no waiting on patents for these goods. They are completed.


RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Taiwan's Bold Bid: From Tech Hub to Capital Magnet

Updated Category News Views 100

Ambitious Plans Unveiled at Taiwan Weeks 2026 Forget the usual humdrum; Taiwan’s pulling no punches in its bid to become a capital powerhouse in Asia. If you'd told me years ago that Taiwan was eyeing dominance in asset management, I might've laughed. But at the 2026 Taiwan Weeks, they showed they're dead serious about it. Over 400 bigwigs and market shakers gathered,...

Continue Reading
Telix Boosts Theranostic Reach with Thera4Care Move

Updated Category News Views 74

Telix's Strategic Move into Theranostics Investing in cancer treatment isn't all about playing defense. Sometimes it's about taking a swing at the next big thing in theranostics. Telix Pharmaceuticals (ASX: TLX, NASDAQ: TLX) has hitched its wagon to the Thera4Care initiative, pushing for a serious expansion of their presence in the European medical field. It's all about...

Continue Reading
GomSpace Targets SEK 1.6 Billion Revenue by 2030

Updated Category News Views 113

GomSpace's Bold Ambition for 2030 The small satellite sector just got a wake-up call from GomSpace. This company has its eyes locked on a jaw-dropping SEK 1.6 billion in revenue by 2030. That's not just some pie-in-the-sky dream. GomSpace is gunning for a calculated annual growth of 30%, riding high on revamped operations and a mighty push into big, juicy contract...

Continue Reading
Citius Unveils Promising LYMPHIR Data at EORTC Conference

Updated Category News Views 84

A Closer Look at LYMPHIR's Impact on CTCL Patients Well, here's a whiff of genuine hope for folks grappling with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Coming out of New Jersey, Citius Oncology has dished out some pretty promising news, fresh from the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group's annual...

Continue Reading
Unum Group Faces Investigation Amid $419.7M Net Loss

Updated Category News Views 61

Troubling Times for Unum Group Investors Alright, folks, let’s get down to brass tacks: Unum Group (NYSE: UNM) is swimming upstream, and not in any leisurely, salmon-like sense. Their third-quarter report revealed a whopping $419.7 million net loss—something that can unsettle even the steadiest ship in the murky waters of the market. Pair that with an SEC...

Continue Reading
BD Appoints Bagnato as Peripheral Intervention Head

Updated Category News Views 86

A New Captain for BD's Peripheral Ship Time to pay attention, folks. Franklin Lakes just sent an interesting ripple through their workforce headlines, announcing Bridget Bagnato taking the reins as Worldwide President of BD's Peripheral Intervention division. Come November 16, this medical tech veteran, who's clocked over 27 years with BD, is set to start steering their...

Continue Reading
Brightstar's iCAP Ready Badge: A Gamble on Responsibility

Updated Category News Views 334

Another Feather in Brightstar's Cap You might not toss 'responsible gaming standards' around in casual talk, but in the gaming biz, it's a badge of honor. Brightstar Lottery PLC (NYSE: BRSL) ain't just spinning wheels here—they've got themselves re-accredited with iCAP Ready from the National Council on Problem Gambling (NCPG). It's the stamp of approval that shows...

Continue Reading
Adient Boosts Buyback, Shields Valuable Tax Assets

Updated Category News Views 47

Adient's Aggressive Buyback and Tax Strategy Well, it looks like Adient's not just sitting on its hands. They've not only opened up the cash taps with a $400 million increase in their share repurchase authorization but also shored up their defenses with a Tax Benefits Preservation Plan. You know, when a company dishes out that kind of cash, it tells you they see some...

Continue Reading
Dircks Expands with Major Phoenix Lease Deal

Updated Category News Views 67

Another Big Win in Phoenix's Industrial Space Who'd have thought? Dircks Moving & Logistics just bagged themselves a hefty 337,897-square-foot lease in Phoenix. This isn’t just any warehouse deal in the Southwest Valley—it’s a mark of where the industrial real estate world’s trending these days. For those who watch these things, they’ve pushed their local space...

Continue Reading
Youdao's Upcoming Q3 2026 Results: What's at Stake?

Updated Category News Views 47

Anticipation Builds Ahead of Youdao's Financial Announcement Okay, folks, if there's one thing investors gotta mark on their calendars, it's Youdao’s upcoming financial results set to drop like a bombshell on November 19, 2026. This ain't just another quarterly report—it's a litmus test for anyone eyeballing the digital learning sector with wallets ready. Youdao: A...

Continue Reading

Top 5 Most Recently Viewed Articles

Dow Inc. Shares Faces Shareholder Class Action Opportunity

Updated Category News Views 291

Investors Affected by Dow Inc.'s Stock Performance Recently, Dow Inc. has encountered significant challenges affecting its stock performance, raising concerns among investors. Those who acquired shares of Dow Inc. (NYSE: DOW) are now presented with an opportunity to lead a shareholder class action lawsuit. This legal action concerns claims against Dow and its executives...

Continue Reading
Northwest Bank's Recognition Illuminates Strategic Strengths

Updated Category News Views 17

A Meaningful Milestone in Northwest Bank's Journey Not every day you hear about a regional player like Northwest Bank cutting through the noise to land on TIME's list of America’s Best Companies. Clocking in at #394 out of 1,000, they seem to be doing something right among the jackals of Wall Street. Folks, they didn't just get there on blind luck—Northwest clawed its...

Continue Reading
Ameren Corporation Launches New Stock Offering Initiative

Updated Category News Views 308

Ameren Corporation Unveils New Stock Offering In a strategic move to bolster its financial position, Ameren Corporation (NYSE: AEE) has announced the pricing of a significant underwritten offering of common stock. The company is set to offer 5,550,416 shares at an attractive public price of $94.00 each. This offering is aimed at facilitating various corporate financial...

Continue Reading
Insights into Nike's Recent Market Movements and Trends

Updated Category News Views 262

Current Market Sentiment on Nike Nike (NKE) has recently seen an increase in its short interest, with a reported 23.96% rise since the last assessment. Currently, there are 44.81 million shares sold short, constituting 4.76% of the company’s total available shares for trading. In the context of trading volume, it is estimated that it would take approximately 1.55 days...

Continue Reading
Investigation Launched into OSI Systems, Inc. Security Practices

Updated Category News Views 165

Investigation into OSI Systems, Inc. by Pomerantz LLP Pomerantz LLP has launched a thorough investigation into the practices of OSI Systems, Inc. (NASDAQ: OSIS) following concerning claims made by investors. The firm is dedicated to uncovering the truth about potential securities violations that may have impacted the company's stakeholders. Allegations of Fraud and...

Continue Reading